Omega-3 Questions Could Pull Plug On Sales Growth
This article was originally published in The Tan Sheet
Executive Summary
Pharma firms’ introduction and wide promotion of Rx drugs containing EPA or DHA acids and aimed at improving cardiovascular health were expected to boost omega-3 supplement sales, but negative research results reported over the past year could diminish consumers’ regard for the nutrients’ benefits.
You may also be interested in...
Omega-3 Use Grows Despite Doubts, Herbals Rise Above NY Controversy
The Council for Responsible Nutrition’s 16th annual survey shows questions raised by researchers, state officials and media about the safety and efficacy of some supplement ingredients do not appear to slowing users’ interest in the products.
Omega-3 Use Grows Despite Doubts, Herbals Rise Above NY Controversy
The Council for Responsible Nutrition’s 16th annual survey shows questions raised by researchers, state officials and media about the safety and efficacy of some supplement ingredients do not appear to slowing users’ interest in the products.
With Pro Ultra Omega-3, Bayer Dives Deeper Into Consumer Health Competition
Bayer HealthCare’s Consumer Care division launches the Pro Ultra brand with the product’s recent debut in the US, leveraging the firm’s presence in the heart health product space.